Development of Pediatric Formulations of the Potassium Channel Opener Ezogabine and the NaV1.6-Selective Sodium Channel Blocker XEN901 for the Treatment of Developmental and Epileptic Encephalopathies
NEUROLOGY（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined